Horizon Therapeutics Public Ltd Co

Clearstead Advisors, LLC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/7/2023

Shares

3,846

Value ($000)

445

Weight

0.0%

2020 Q3 - 2023 Q3 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/7/2023	445	0.0%	3,846	9/30/2023
2023 Q2	8/7/2023	396	0.0%	3,846	6/30/2023
2023 Q1	5/9/2023	420	0.0%	3,846	3/31/2023
2022 Q4	2/14/2023	448	0.0%	3,937	12/31/2022
2022 Q3	11/15/2022	244	0.0%	3,937	9/30/2022
2022 Q2	8/12/2022	314	0.0%	3,937	6/30/2022
2022 Q1	5/4/2022	407	0.0%	3,871	3/31/2022
2021 Q4	2/14/2022	417	0.0%	3,871	12/31/2021
2021 Q3	11/12/2021	424	0.0%	3,871	9/30/2021
2021 Q2	8/12/2021	362	0.0%	3,871	6/30/2021
2021 Q1	5/14/2021	356	0.0%	3,871	3/31/2021
2020 Q4	2/11/2021	283	0.0%	3,871	12/31/2020
2020 Q3	11/12/2020	301	0.0%	3,871	9/30/2020